2024 Spain Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

August 2024 | - | ID: 229F5A23B07CEN
Venture Planning Group

Abstracts

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.This new study from VPGMarketResearch contains 407 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.

Contents

Introduction
Global Market Trends and Emerging Technologies
A. DNA Sequencing
B. DNA and RNA Probe Technology
C. Detection Technologies
D. Instrumentation: Review of Automated and Semi-Automated Analyzers
E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
F. Pharmacogenomics
G. Cancer Molecular Diagnostics Testing

1. OVERVIEW

2. MAJOR CANCER TYPES

3. ONCOGENES

H. Genetic Diseases Molecular Diagnostic Testing

1. OVERVIEW

2. NUCLEIC ACID AMPLIFICATION

3. CHROMOSOME IMAGING

4. GENOMICS TECHNOLOGIES

5. PROTEOMICS TECHNOLOGIES

6. CURRENT PHARMACOGENOMIC TESTING

7. MAJOR DISEASES

I. Forensic Molecular Diagnostics Testing

1. OVERVIEW

2. MULTILOCUS AND SINGLE LOCUS PROBES

3. THE FBI

Table of Contents (continued)

4. DNA PROFILE DATA BANKS

5. JUDICIAL IMPLEMENTATION

6. MAJOR CRIME CATEGORIES

7. FACTORS CONTRIBUTING TO THE DNA PROBE

Major Expansion
J. Paternity Testing/HLA Typing Molecular Diagnostic Testing
K. Other Molecular Diagnostic Testing Applications
L. Competing/Complementing Technologies
Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Market Segment
- Sales Forecasts by Market Segment
- Major Supplier Sales and Market Shares
Major Product Development Opportunities
A. Opportunities for New Instrumentation
B. Opportunities for New Reagent Kits and Test Systems/Panels
C. Opportunities for New IT, Computers, Software and Automation
D. Opportunities for New Auxiliary Products
Design Criteria For Decentralized Testing Products
Alternative Market Penetration Strategies
Potential Market Entry Barriers And Risks
Competitive Profiles
- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies